GSI 150 (Viread 150 mg)

Generic Name: tenofovir

Pill imprint GSI 150 has been identified as Viread 150 mg.

Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for GSI 150 (Viread 150 mg)

Viread
Generic Name:
tenofovir
Imprint:
GSI
150
Strength:
150 mg
Color:
White
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-0404
Inactive Ingredients:
corn starch
croscarmellose sodium
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
triacetin
hypromellose 2910 (15000 mPa.s)

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)